How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Biological Detection Equipment Market
- By Product Type: Handheld Detectors, Portable Detectors, Fixed Detectors, Wearable Detectors, Laboratory Analyzers
- By Technology: Immunoassay-based Detection, Polymerase Chain Reaction (PCR), Mass Spectrometry, Biosensors, Fluorescence Detection
- By Application: Military and Defense, Healthcare and Diagnostics, Environmental Monitoring, Food Safety Testing, Bioterrorism Detection
- By End User: Government and Defense Agencies, Hospitals and Clinical Laboratories, Environmental Agencies, Food and Beverage Industry, Research Institutions
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Handheld Detectors leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 281 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.170 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.178 →
Full report · locked preview
Everything inside the Biological Detection Equipment Market report
A complete, evidence-based study - 11 chapters and 118 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Product Type 5
Technology 5
Application 5
End User 5
Companies profiled
Thermo Fisher Scientific
PerkinElmer Inc.
Bio-Rad Laboratories
Agilent Technologies
Bruker Corporation
Merck KGaA (MilliporeSigma)
QIAGEN N.V.
Danaher Corporation
Luminex Corporation
Smiths Detection
FLIR Systems (Teledyne Technologies)
Canary Health
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Thermo Fisher Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →PerkinElmer Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Bio-Rad Laboratories
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Agilent Technologies
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Bruker Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Merck KGaA (MilliporeSigma)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →QIAGEN N.V.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Danaher Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Luminex Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Smiths Detection
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →FLIR Systems (Teledyne Technologies)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Canary Health
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Roche Diagnostics
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →BioFire Diagnostics (a bioMérieux company)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Hach Company
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →
Global · 2025–2033
$7,463M by 2033 · 8.9% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Handheld Detectors49.5
- Portable Detectors10.6
- Fixed Detectors10.0
- Wearable Detectors14.8
- Laboratory Analyzers15.1
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,246M → $2,751M · 10.4%
Europe$868.7M → $1,679M · 8.6%
Asia Pacific$793.2M → $1,649M · 9.6%
Latin America$491.0M → $903.6M · 7.9%
Middle East and Africa$377.7M → $777.5M · 9.4%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →8.842026
8.852027
8.862028
8.882029
8.892030
8.892031
8.912032
8.922033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Thermo Fisher Scientific20.2
- PerkinElmer Inc.25.8
- Bio-Rad Laboratories4.9
- Agilent Technologies5.0
- Bruker Corporation11.0
- Merck KGaA (MilliporeSigma)5.1
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type36.1%
Technology13.6%
Application19.2%
End User31.0%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America35.5
- Europe21.6
- Asia Pacific21.2
- Latin America11.6
- Middle East and Africa10.0
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | 83 | 89 | 90 | 96 | 91 | 96 | 91 |
| PerkinElmer Inc. | 82 | 92 | 75 | 75 | 78 | 76 | 80 |
| Bio-Rad Laboratories | 76 | 79 | 86 | 81 | 77 | 83 | 80 |
| Agilent Technologies | 61 | 82 | 82 | 57 | 59 | 64 | 68 |
| Bruker Corporation | 68 | 65 | 71 | 66 | 68 | 72 | 68 |
| Merck KGaA (MilliporeSigma) | 58 | 58 | 56 | 64 | 64 | 70 | 62 |
| QIAGEN N.V. | 41 | 47 | 43 | 63 | 40 | 66 | 50 |
| Danaher Corporation | 44 | 41 | 49 | 44 | 55 | 47 | 47 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Thermo Fisher Scientific
- PerkinElmer Inc.
- Bio-Rad Laboratories
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | ◐ | ✓ | ✓ | ✓ | ✓ | ✓ |
| PerkinElmer Inc. | ◐ | ✓ | ◐ | ✓ | ◐ | ◐ |
| Bio-Rad Laboratories | ✓ | ✓ | ✓ | ✓ | ◐ | ◐ |
| Agilent Technologies | − | ◐ | ✓ | ◐ | ◐ | ◐ |
| Bruker Corporation | ◐ | ◐ | ◐ | ✓ | ✓ | ◐ |
| Merck KGaA (MilliporeSigma) | − | − | − | − | ◐ | ◐ |
| QIAGEN N.V. | − | − | − | ✓ | ◐ | ◐ |
| Danaher Corporation | − | − | ◐ | ◐ | ◐ | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Thermo Fisher Scientific91
2PerkinElmer Inc.80
3Bio-Rad Laboratories80
4Agilent Technologies68
5Bruker Corporation68
6Merck KGaA (MilliporeSigma)62
7QIAGEN N.V.50
8Danaher Corporation47
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Thermo Fisher ScientificPerkinElmer Inc.Bio-Rad Laboratories
Challenger2
Strong scale, closing on the leaders.
Agilent TechnologiesBruker Corporation
Contender1
Focused players with pockets of strength.
Merck KGaA (MilliporeSigma)
Niche2
Specialists in a single segment or region.
QIAGEN N.V.Danaher Corporation
Go-to-market strategy
Land Product Type in North America, then scale across Biological Detection Equipment Market — a $195M beachhead inside a $2.73B market.
Beachhead (SOM)$195Mobtainable near-term
Serviceable (SAM)$1.05Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion90 fit
Handheld Detectors
Best fit — highest urgency & budget in Product Type.
Economic buyer80 fit
Portable Detectors
Strong fit — clear ROI and a fast path to value.
End user69 fit
Fixed Detectors
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Technology & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel25%
Digital / self-serve22%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Biological Detection Equipment Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified38%
Sales qualified21%
Evaluation14%
Closed-won7%
$18.4KCAC
$83KLTV
4.5:1LTV : CAC
< 3 moCAC payback
Investment thesis
Biological Detection Equipment Market is a durable-growth opportunity — $6.92B by 2033, compounding at 8.9%.
TAM · 2025$3.51Btoday
TAM · 2033$6.92Bforecast
CAGR8.9%2027–2033
Cumulative$45.5Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$6.92BTotal addressable market
SAM$2.88BServiceable available market
SOM$627MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →8.9% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$6.92BLarge & growingTAM by 2033 at 8.9% CAGR
$2.88BServiceable nowreachable with today’s model
$627MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.40BBear5.8% CAGR
$6.92BBase8.9% CAGR
$8.86BBull11.7% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Technology optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Biological Detection Equipment Market — a $716M market by 2033. Plan: grow share from 11.1% to 17.4%.
Market size · 2033$716Mtotal addressable
Market CAGR4.7%2027–2033
Target share17.4%from 11.1% today
Revenue ambition$125Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 11.1% | 17.4% | At risk |
| Revenue | $76M | $125M | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | On track |
| Gross margin | 33.3% | 41.8% | On track |
| Customer retention | 90.7% | 92.7% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Technology capability
A defensible second engine — invest in Technology to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Technology
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $14M capacity & capability investment
- Greenlight bolt-on M&A in Technology
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossOn track
- Input-cost & supply riskAt risk
- Regulatory / policy changeOn track
- Execution & talentOn track
Sales deck · value proposition
Win the Biological Detection Equipment Market conversation — a $1.13B market you can size, segment and defend in minutes.
Market size · 2033$1.13Btotal opportunity
Growth6.1%CAGR to 2033
Addressable buyers1,487+accounts in scope
Typical ROI4.2×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.2×return on cost, year one
< 2 mopayback period
$62K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Thermo Fisher ScientificPerkinElmer Inc.Bio-Rad LaboratoriesAgilent TechnologiesBruker CorporationMerck KGaA (MilliporeSigma)QIAGEN N.V.Danaher Corporation+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Biological Detection Equipment Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Biological Detection Equipment Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Biological Digital Microscopes Market
Market size, share, segmentation and regional forecast.
$3.8B market · 2025 base year
View reportBiological Disinfectant Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportBiological Drug Api Manufacturing Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportBiological Drug Detector Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportBiological Engineering Equipment Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportBiological Fermentation System Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportBiological Fermentation Tank Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportBiological Fertilizer Fungicide Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportBiological Glue Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportBiological Heart Valve Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportBiological Heart Valves Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportBiological Ice Bag Market
Market size, share, segmentation and regional forecast.
$477M market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report ships as a formatted PDF, a fully editable XLSX containing all underlying data tables, and a presentation-ready PPT deck - so you can re-chart, re-model, or drop any figure straight into your own deck.